Bellevue Life Sciences Acquisition Corp (BLAC)

$10.83

Market is closed - opens 7 PM, 09 Sep 2024

Performance

  • $10.83
    $10.83
    $10.83
    downward going graph

    0.05%

    Downside

    Day's Volatility :0.05%

    Upside

    0.0%

    downward going graph
  • $10.38
    $11.60
    $10.83
    downward going graph

    4.16%

    Downside

    52 Weeks Volatility :10.52%

    Upside

    6.64%

    downward going graph

Returns

PeriodBellevue Life Sciences Acquisition CorpIndex (Russel 2000)
3 Months
0.74%
0.0%
6 Months
1.79%
0.0%
1 Year
4.34%
0.0%
3 Years
7.23%
-22.3%

Highlights

Market Capitalization
43.7M
Book Value
- $1.21
Earnings Per Share (EPS)
-0.04
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-2.98%
Return On Equity TTM
0.0%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
Diluted Eps TTM
-0.04
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Technicals Summary

Sell

Neutral

Buy

Bellevue Life Sciences Acquisition Corp is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Bellevue Life Sciences Acquisition Corp
Bellevue Life Sciences Acquisition Corp
-1.01%
1.79%
4.34%
7.23%
7.23%
Screaming Eagle Acquisition Corp
Screaming Eagle Acquisition Corp
-15.89%
-39.21%
-39.21%
-38.04%
-38.04%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Bellevue Life Sciences Acquisition Corp
Bellevue Life Sciences Acquisition Corp
540.25
NA
NA
0.0
0.0
-0.03
NA
-1.21
Screaming Eagle Acquisition Corp
Screaming Eagle Acquisition Corp
NA
NA
NA
0.0
0.0
0.0
NA
-0.41
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Bellevue Life Sciences Acquisition Corp
Bellevue Life Sciences Acquisition Corp
NA
$43.7M
7.23%
540.25
0.0%
Screaming Eagle Acquisition Corp
Screaming Eagle Acquisition Corp
NA
$1.9B
-38.04%
NA
0.0%

Company Information

Organization
Bellevue Life Sciences Acquisition Corp
Employees
0
CEO
Mr. Kuk Hyoun Hwang
Industry
Miscellaneous

FAQs